Phathom Pharmaceuticals (PHAT) Capital Expenditures (QoQ) (2020 - 2026)
Phathom Pharmaceuticals (PHAT) Capital Expenditures (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Phathom Pharmaceuticals | 951.79 Mn | 768.02 Mn | 46.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -94.80% |
| Dec 31, 2025 | 1,932.81% |
| Sep 30, 2025 | -155.65% |
| Dec 31, 2024 | -201.67% |
| Sep 30, 2024 | 500.00% |
| Jun 30, 2024 | -175.00% |
| Mar 31, 2024 | 101.95% |
| Dec 31, 2023 | -159.59% |
| Dec 31, 2022 | -183.36% |
| Sep 30, 2022 | 1,301.96% |
| Jun 30, 2022 | -176.12% |
| Mar 31, 2022 | 48.89% |
| Dec 31, 2021 | -10.00% |
| Sep 30, 2021 | 119.08% |
| Jun 30, 2021 | -255.03% |
| Mar 31, 2021 | 3.05% |
| Dec 31, 2020 | 763.16% |
| Sep 30, 2020 | 110.56% |
| Jun 30, 2020 | -190.00% |
| Mar 31, 2020 | 88.68% |